Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01079208 · ClinicalTrials.gov registry record · NA
Growth of Infants Fed New Starter Formula
A NA study, sponsored by Société des Produits Nestlé (SPN).
- Completed
- Registry status
- NA
- Development phase
- 297
- Enrollment target
NCT01079208 is a NA study that has completed, run by Société des Produits Nestlé (SPN). The registered enrollment target is 297 participants.
The verdict
NCT01079208, a NA study, has completed, sponsored by Société des Produits Nestlé (SPN).
- COMPLETED
- Registry status
- NA
- Development phase
- 297 participants
- Enrollment target
Study Summary
The purpose of this study is to assess the growth of infants fed a novel starter formula containing synbiotics and different protein levels, compared to a standard starter infant formula, during the first four months of life.
Interventions
- OTHER test starter infant formula
- OTHER test starter infant formula with synbiotics
- OTHER control standard formula
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 297 participants |
| Start Date | 2010-03 |
| Est. Completion | 2014-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01079208
The ClinicalTrials.gov registry entry for NCT01079208 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 297 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Société des Produits Nestlé (SPN), which has 53 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which test starter infant formula is the first listed.
NCT01079208 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01079208 about?
NCT01079208 is a clinical study titled "Growth of Infants Fed New Starter Formula". The purpose of this study is to assess the growth of infants fed a novel starter formula containing synbiotics and different protein levels, compared to a standard starter infant formula, during the first four months of life.
What is the current status of trial NCT01079208?
This trial is currently completed. It is a NA study. The enrollment target is 297 participants. The study started on 2010-03. Estimated completion is 2014-10.
What interventions are being tested in trial NCT01079208?
The interventions under investigation include: test starter infant formula (OTHER), test starter infant formula with synbiotics (OTHER), control standard formula (OTHER).
Who is sponsoring clinical trial NCT01079208?
This trial is sponsored by Société des Produits Nestlé (SPN), which has 53 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.